SOSV

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Michael Aberman

Partner

Lindsay Atkenson

Analyst

Hugh Bowen

Associate

Po Bronson

General Partner

Stephen Chambers

Partner

Navin Danapal

SEA Director

Hiruy Ephrem

Analyst

Sheng Ge

Partner, Investments Operations

Weichang Ge

Analyst

TR Harrington

Partner

Bill Liao

General Partner

Ching-Ping Lin

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Yuan-Ting Meng

Analyst

Paul Monaghan

Principal

Eric Ramsay

Analyst

Pae Wu

General Partner

Sabriya Stukes Ph.D

Partner

Past deals in API

Atato

Series A in 2022
Atato is a digital assets technology company based in Bangkok, Thailand, founded in 2017. The company specializes in developing customized blockchain platforms that enable businesses to connect with blockchain networks and harness the advantages of blockchain technology. Atato focuses on creating next-generation infrastructure for the issuance and management of digital assets. It offers software solutions that facilitate the transfer of value over the Internet and provide advanced data analysis, visualization, and actionable intelligence. These tools help financial institutions interact with blockchain-based businesses while ensuring compliance and safeguarding the integrity of cryptocurrency transactions.

AYLIEN

Convertible Note in 2021
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.

Atato

Seed Round in 2021
Atato is a digital assets technology company based in Bangkok, Thailand, founded in 2017. The company specializes in developing customized blockchain platforms that enable businesses to connect with blockchain networks and harness the advantages of blockchain technology. Atato focuses on creating next-generation infrastructure for the issuance and management of digital assets. It offers software solutions that facilitate the transfer of value over the Internet and provide advanced data analysis, visualization, and actionable intelligence. These tools help financial institutions interact with blockchain-based businesses while ensuring compliance and safeguarding the integrity of cryptocurrency transactions.

OaCP

Convertible Note in 2020
OaCP Srl, established in 2017 and based in Bologna, Italy, specializes in developing and patenting proprietary reagents that significantly enhance the efficiency of genetic tests for cancer diagnosis. The company's innovations reduce the turnaround time for diagnostic tests from three days to just two hours while cutting costs by 50%. OaCP's offerings include various reagents and the OaCP Fast Bath, a waterbath instrument, used in Fluorescence in Situ Hybridization (FISH) diagnostics. Their products cater to diverse sectors such as biomedical, biotechnology, pharmaceuticals, and public health, serving patients, clinicians, entrepreneurs, and researchers. OaCP has secured distribution agreements in Italy and Japan and continues to pursue business expansion and product development, having received seed investment and participated in an accelerator program.

AYLIEN

Series A in 2019
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.

Honeycomb

Seed Round in 2019
Honeycomb is an API marketplace that connects smart contracts to external data inputs from premier data providers. Smart contracts can query APIs on Honeycomb via decentralized chainlink oracles, enabling the contract to execute in a reliable, end-to-end secure manner on networks like Ethereum, Bitcoin, and Hyperledger. Honeycomb reduces the amount of time smart contract developers spend searching for viable data sources, and increase the amount of time they spend building smart contracts. Honeycomb is headquartered in Munich, Germany.

API3

Pre Seed Round in 2019
API3 is a company based in the Cayman Islands that focuses on creating decentralized application programming interfaces (APIs) for web use. It develops a decentralized API infrastructure designed to connect blockchain applications with off-chain data providers. API3 aggregates data from first-party oracles operated by leading API providers, allowing data providers to serve as their own blockchain oracles without the need for third-party intermediaries. The platform addresses the challenges of API connectivity by utilizing a decentralized approach, ensuring secure and quantifiable data feeds for decentralized applications.

Advanced Planet

Seed Round in 2019
Advanced Planet Co., LTD, founded in 2018 and based in Taipei, Taiwan, with additional operations in Moscow, Russia, specializes in developing software that facilitates personalized offers tailored to users' interests and lifestyles. Its flagship product, LeapMe, is an application available on Android and iOS that allows users to receive discount coupons and relevant content from brands in specific locations, such as where they book hotels or restaurants. LeapMe empowers users to take control of their personal data, enabling them to share it with brands in exchange for better deals and rewards. The platform also supports businesses in establishing a direct communication channel with their target audiences, enhancing engagement and marketing opportunities.

Appa Life

Seed Round in 2018
Appa Life Co. specializes in the production of nutraceuticals and dietary supplements aimed at managing long-term pain for athletes. Founded in 2018 and based in the United States, the company operates as a vertically integrated entity, controlling its supply chain from formulation to production. This approach allows Appa Life to provide detailed information about the ingredients used in its products, which are available for purchase online.

OaCP

Convertible Note in 2018
OaCP Srl, established in 2017 and based in Bologna, Italy, specializes in developing and patenting proprietary reagents that significantly enhance the efficiency of genetic tests for cancer diagnosis. The company's innovations reduce the turnaround time for diagnostic tests from three days to just two hours while cutting costs by 50%. OaCP's offerings include various reagents and the OaCP Fast Bath, a waterbath instrument, used in Fluorescence in Situ Hybridization (FISH) diagnostics. Their products cater to diverse sectors such as biomedical, biotechnology, pharmaceuticals, and public health, serving patients, clinicians, entrepreneurs, and researchers. OaCP has secured distribution agreements in Italy and Japan and continues to pursue business expansion and product development, having received seed investment and participated in an accelerator program.

AYLIEN

Venture Round in 2017
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.

OaCP

Seed Round in 2017
OaCP Srl, established in 2017 and based in Bologna, Italy, specializes in developing and patenting proprietary reagents that significantly enhance the efficiency of genetic tests for cancer diagnosis. The company's innovations reduce the turnaround time for diagnostic tests from three days to just two hours while cutting costs by 50%. OaCP's offerings include various reagents and the OaCP Fast Bath, a waterbath instrument, used in Fluorescence in Situ Hybridization (FISH) diagnostics. Their products cater to diverse sectors such as biomedical, biotechnology, pharmaceuticals, and public health, serving patients, clinicians, entrepreneurs, and researchers. OaCP has secured distribution agreements in Italy and Japan and continues to pursue business expansion and product development, having received seed investment and participated in an accelerator program.

A2A Pharmaceuticals

Convertible Note in 2016
A2A Pharmaceuticals, Inc. is a biotechnology company based in New York, established in 2016, that specializes in developing innovative drugs to combat antibiotic-resistant bacterial infections, tuberculosis, and cancer. The company employs a unique therapeutic design methodology that focuses on inhibiting protein-protein interactions and utilizes bioinformatics techniques specifically for gram-negative bacterial species. A2A Pharmaceuticals integrates computational tools and interdisciplinary approaches in its drug development process, leveraging its proprietary SCULPTâ„¢ platform to systematically design therapeutic candidates based on experimentally determined target characteristics. In addition to its research and development efforts, the company also offers consulting services to support advancements in the pharmaceutical field.

A2A Pharmaceuticals

Seed Round in 2016
A2A Pharmaceuticals, Inc. is a biotechnology company based in New York, established in 2016, that specializes in developing innovative drugs to combat antibiotic-resistant bacterial infections, tuberculosis, and cancer. The company employs a unique therapeutic design methodology that focuses on inhibiting protein-protein interactions and utilizes bioinformatics techniques specifically for gram-negative bacterial species. A2A Pharmaceuticals integrates computational tools and interdisciplinary approaches in its drug development process, leveraging its proprietary SCULPTâ„¢ platform to systematically design therapeutic candidates based on experimentally determined target characteristics. In addition to its research and development efforts, the company also offers consulting services to support advancements in the pharmaceutical field.

Kajin, Inc.

Seed Round in 2016
Kajin, Inc. operates an online therapy and counseling platform specifically designed for Chinese-speaking Asians. Established in 2015 and headquartered in Taipei, Taiwan, the company offers a real-time platform that utilizes live video sessions to connect users with certified therapists. Kajin aims to address mental health issues within minority communities, focusing on reducing stigma and increasing access to mental health resources for the Chinese community. The platform allows patients and counselors to connect anytime and anywhere, facilitating support and guidance for those in need.

AYLIEN

Venture Round in 2016
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.

Asyncode Limited

Seed Round in 2014
Online services such as Facebook, LinkedIn etc. collect huge amounts of data. However their typical user can't benefit from the wealth of information available there! Accessing the data requires advanced programming skills and hours if not days of learning different APIs. Asyncode is the simple way to work with data stored in the cloud or generated by sensors. Users can create their own data solutions by building recipes. A recipe is a set of simple steps that tell our servers where to get data from, what to do with them and how to visualize the result. A basic example would be getting user's followers from Twitter and displaying the location of their last tweet on a map or taking all blog posts from a Tumblr account and, using a text analysis API, tagging automatically each of them.

AYLIEN

Seed Round in 2011
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.

AYLIEN

Seed Round in 2010
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.